Ritholtz Wealth Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Ritholtz Wealth Management's EW Position: Q3 2026 in Review
Ritholtz Wealth Management increased its Edwards Lifesciences (EW) stake by 92% in Q3 2026, buying an estimated $644K and bringing the position to 15,148 shares worth $1.31M. The position accounts for 0.02% of the portfolio, ranked #570.
Ritholtz Wealth Management first reported a position in EW in Q4 2021 and has held it in 14 quarters since. 774 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Ritholtz Wealth Management held 15,148 shares of Edwards Lifesciences worth $1.31M as of Q3 2026.
- Ritholtz Wealth Management bought 7,241 Edwards Lifesciences shares in Q3 2026, an estimated $644K.
- Edwards Lifesciences made up 0.02% of Ritholtz Wealth Management's portfolio in Q3 2026, its #570 holding.
- Ritholtz Wealth Management first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 14 quarters since.
- 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Ritholtz Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.